Cognitive Fitness to Drive in Huntington's Disease: Assessing the Clinical Utility of DriveSafe DriveAware

Hayden J. Farrell, Sophie C. Andrews, Nicholas P. Ryan, Marie Claire Davis, Stephanie Gordon, Julie C. Stout, Fiona Fisher

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Background: DriveSafe DriveAware (DSDA) has been validated as an off-road screening tool for predicting on-road driving performance in clinical populations, but its utility in people with Huntington's disease (HD) is unknown. Objective: Our aim was to evaluate the utility of DSDA in people with HD by demonstrating sensitivity of DSDA scores to HD progression and exploring associations between DSDA performance and cognitive functions that are essential to driving and impaired in people with HD. Methods: We administered the iPad application version of DSDA to 26 pre-symptomatic and symptomatic participants with HD. Disease progression was assessed via measures of motor impairment, disease burden and functional capacity. Standardised neuropsychological tests were used to assess cognitive function across several domains including attention, processing speed, planning, and visuoperception. Results: Results underscore the sensitivity of DSDA to HD progression and cognitive impairment; that is, poorer DSDA performance was associated with greater HD severity and poorer cognitive ability across the domains of attention, processing speed, and planning. Nevertheless, we identified a proportion of participants with HD who were predicted to pass on-road testing based on DSDA, but scored in the impaired range on multiple cognitive tests. These participants tended to score closer to the cut-off score used by DSDA to categorise pass/fail outcomes. Conclusions: Our findings demonstrate potential for use of DSDA in the HD population, however, significant variability in cognitive performance among those predicted to 'pass' on-road driving assessment suggests the screening tool requires further development for use with HD drivers.

Original languageEnglish
Pages (from-to)87-95
Number of pages9
JournalJournal of Huntington's Disease
Volume8
Issue number1
DOIs
Publication statusPublished - 13 Feb 2019

Keywords

  • automobile driving
  • cognitive dysfunction
  • disease progression
  • Huntington's disease

Cite this

Farrell, Hayden J. ; Andrews, Sophie C. ; Ryan, Nicholas P. ; Davis, Marie Claire ; Gordon, Stephanie ; Stout, Julie C. ; Fisher, Fiona. / Cognitive Fitness to Drive in Huntington's Disease : Assessing the Clinical Utility of DriveSafe DriveAware. In: Journal of Huntington's Disease. 2019 ; Vol. 8, No. 1. pp. 87-95.
@article{c46aea0ee80446e794ead0b6af097b83,
title = "Cognitive Fitness to Drive in Huntington's Disease: Assessing the Clinical Utility of DriveSafe DriveAware",
abstract = "Background: DriveSafe DriveAware (DSDA) has been validated as an off-road screening tool for predicting on-road driving performance in clinical populations, but its utility in people with Huntington's disease (HD) is unknown. Objective: Our aim was to evaluate the utility of DSDA in people with HD by demonstrating sensitivity of DSDA scores to HD progression and exploring associations between DSDA performance and cognitive functions that are essential to driving and impaired in people with HD. Methods: We administered the iPad application version of DSDA to 26 pre-symptomatic and symptomatic participants with HD. Disease progression was assessed via measures of motor impairment, disease burden and functional capacity. Standardised neuropsychological tests were used to assess cognitive function across several domains including attention, processing speed, planning, and visuoperception. Results: Results underscore the sensitivity of DSDA to HD progression and cognitive impairment; that is, poorer DSDA performance was associated with greater HD severity and poorer cognitive ability across the domains of attention, processing speed, and planning. Nevertheless, we identified a proportion of participants with HD who were predicted to pass on-road testing based on DSDA, but scored in the impaired range on multiple cognitive tests. These participants tended to score closer to the cut-off score used by DSDA to categorise pass/fail outcomes. Conclusions: Our findings demonstrate potential for use of DSDA in the HD population, however, significant variability in cognitive performance among those predicted to 'pass' on-road driving assessment suggests the screening tool requires further development for use with HD drivers.",
keywords = "automobile driving, cognitive dysfunction, disease progression, Huntington's disease",
author = "Farrell, {Hayden J.} and Andrews, {Sophie C.} and Ryan, {Nicholas P.} and Davis, {Marie Claire} and Stephanie Gordon and Stout, {Julie C.} and Fiona Fisher",
year = "2019",
month = "2",
day = "13",
doi = "10.3233/JHD-180323",
language = "English",
volume = "8",
pages = "87--95",
journal = "Journal of Huntington's Disease",
issn = "1879-6397",
publisher = "IOS Press",
number = "1",

}

Cognitive Fitness to Drive in Huntington's Disease : Assessing the Clinical Utility of DriveSafe DriveAware. / Farrell, Hayden J.; Andrews, Sophie C.; Ryan, Nicholas P.; Davis, Marie Claire; Gordon, Stephanie; Stout, Julie C.; Fisher, Fiona.

In: Journal of Huntington's Disease, Vol. 8, No. 1, 13.02.2019, p. 87-95.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Cognitive Fitness to Drive in Huntington's Disease

T2 - Assessing the Clinical Utility of DriveSafe DriveAware

AU - Farrell, Hayden J.

AU - Andrews, Sophie C.

AU - Ryan, Nicholas P.

AU - Davis, Marie Claire

AU - Gordon, Stephanie

AU - Stout, Julie C.

AU - Fisher, Fiona

PY - 2019/2/13

Y1 - 2019/2/13

N2 - Background: DriveSafe DriveAware (DSDA) has been validated as an off-road screening tool for predicting on-road driving performance in clinical populations, but its utility in people with Huntington's disease (HD) is unknown. Objective: Our aim was to evaluate the utility of DSDA in people with HD by demonstrating sensitivity of DSDA scores to HD progression and exploring associations between DSDA performance and cognitive functions that are essential to driving and impaired in people with HD. Methods: We administered the iPad application version of DSDA to 26 pre-symptomatic and symptomatic participants with HD. Disease progression was assessed via measures of motor impairment, disease burden and functional capacity. Standardised neuropsychological tests were used to assess cognitive function across several domains including attention, processing speed, planning, and visuoperception. Results: Results underscore the sensitivity of DSDA to HD progression and cognitive impairment; that is, poorer DSDA performance was associated with greater HD severity and poorer cognitive ability across the domains of attention, processing speed, and planning. Nevertheless, we identified a proportion of participants with HD who were predicted to pass on-road testing based on DSDA, but scored in the impaired range on multiple cognitive tests. These participants tended to score closer to the cut-off score used by DSDA to categorise pass/fail outcomes. Conclusions: Our findings demonstrate potential for use of DSDA in the HD population, however, significant variability in cognitive performance among those predicted to 'pass' on-road driving assessment suggests the screening tool requires further development for use with HD drivers.

AB - Background: DriveSafe DriveAware (DSDA) has been validated as an off-road screening tool for predicting on-road driving performance in clinical populations, but its utility in people with Huntington's disease (HD) is unknown. Objective: Our aim was to evaluate the utility of DSDA in people with HD by demonstrating sensitivity of DSDA scores to HD progression and exploring associations between DSDA performance and cognitive functions that are essential to driving and impaired in people with HD. Methods: We administered the iPad application version of DSDA to 26 pre-symptomatic and symptomatic participants with HD. Disease progression was assessed via measures of motor impairment, disease burden and functional capacity. Standardised neuropsychological tests were used to assess cognitive function across several domains including attention, processing speed, planning, and visuoperception. Results: Results underscore the sensitivity of DSDA to HD progression and cognitive impairment; that is, poorer DSDA performance was associated with greater HD severity and poorer cognitive ability across the domains of attention, processing speed, and planning. Nevertheless, we identified a proportion of participants with HD who were predicted to pass on-road testing based on DSDA, but scored in the impaired range on multiple cognitive tests. These participants tended to score closer to the cut-off score used by DSDA to categorise pass/fail outcomes. Conclusions: Our findings demonstrate potential for use of DSDA in the HD population, however, significant variability in cognitive performance among those predicted to 'pass' on-road driving assessment suggests the screening tool requires further development for use with HD drivers.

KW - automobile driving

KW - cognitive dysfunction

KW - disease progression

KW - Huntington's disease

UR - http://www.scopus.com/inward/record.url?scp=85061907491&partnerID=8YFLogxK

U2 - 10.3233/JHD-180323

DO - 10.3233/JHD-180323

M3 - Article

VL - 8

SP - 87

EP - 95

JO - Journal of Huntington's Disease

JF - Journal of Huntington's Disease

SN - 1879-6397

IS - 1

ER -